Generex Biotechnology Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
5
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
5
Upside
0.00%
Analysts
0
Price Target
$0.00

Generex Biotechnology Stock Forecast and Price Target

Generex Biotechnology's stock price reaches the average target of $0.00 by 2025 as expected recently by notable experts, there would be a potential upside of approximately 100% from the last closing price in January, 2023. This possible increase is based on a high estimate of $0.00 and a low estimate of $0.00.

$0.00

0.00% Upside

-

Generex Biotechnology Fair Value Forecast for 2023 - 2025 - 2030

Generex Biotechnology Revenue Forecast for 2023 - 2025 - 2030

Generex Biotechnology Dividend per Share Forecast for 2023 - 2025 - 2030

Generex Biotechnology Free Cash Flow Forecast for 2023 - 2025 - 2030

Generex Biotechnology EBITDA Forecast for 2023 - 2025 - 2030

Generex Biotechnology EBIT Forecast for 2023 - 2025 - 2030

Generex Biotechnology EPS Price Prediction Forecast for 2023 - 2025 - 2030